Evidence map›Paper›PMID 26147678›Full record

ReviewCurrent opinion in organ transplantation2015

Organ-specific differences in achieving tolerance.

Maria Lucia L Madariaga, Daniel Kreisel, Joren C Madsen

Abstract readReview
In one paragraph

Review in Current opinion in organ transplantation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Tolerogenic Therapies in Cardiac Transplantation.International journal of molecular sciences · 2025
    Review
  6. Article
  7. Review
  8. Intragraft B cell differentiation during the development of tolerance to kidney allografts is associated with a regulatory B cell signature revealed by single cell transcriptomics.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2023
    Article
  9. Article
  10. Article
  11. Review
  12. Ischemia reperfusion injury facilitates lung allograft acceptance through IL-33-mediated activation of donor-derived IL-5 producing group 2 innate lymphoid cells.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  13. Sex and organ-specific risk of major adverse renal or cardiac events in solid organ transplant recipients with COVID-19.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maria Lucia L MadariagaaCenter for Transplantation Science, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts bDivision of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St Louis, Missouri cDivision of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Daniel Kreisel
Joren C Madsen

Funding

XENOGENIC TOLERANCE IN MICEP01HL018646 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MADSEN, JOREN C · 1985 to 2019
$37.5M
THE ROLE OF ISCHEMIA REPERFUSION INJURY IN LUNG ALLOGRAFT REJECTIONR01HL094601 · NHLBI · WASHINGTON UNIVERSITY · PI Andrew Eric Gelman, Daniel Kreisel · 2009 to 2026
$6.9M
Tolerance Strategies in Non-Human Primate Cardiac Allograft RecipientsU01AI094374 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MADSEN, JOREN C · 2010 to 2016
$5.9M
MECHANISMS OF LUNG ALLOGRAFT ACCEPTANCER01HL113931 · NHLBI · WASHINGTON UNIVERSITY · PI KREISEL, DANIEL, KRUPNICK, ALEXANDER S. · 2012 to 2015
$1.5M
AMELIORATION OF THE DELETERIOUS EFFECTS OF DONOR BRAIN DEATHF32HL117540 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MADARIAGA, MARIA LUCIA · 2013 to 2014
$110k
NHLBI NIH HHS F32 HL117540NHLBI NIH HHS F32HL117540NHLBI NIH HHS P01 HL018646NHLBI NIH HHS P01HL18646NHLBI NIH HHS R01 HL094601NHLBI NIH HHS R01HL094601NHLBI NIH HHS R01 HL113931NHLBI NIH HHS R01HL113931NIAID NIH HHS U01 AI094374NIAID NIH HHS U01AI94374
6 · The paper itself

Abstract

purpose of reviewWhen it comes to tolerance induction, kidney allografts behave differently from heart allografts that behave differently from lung allografts. Here, we examine how and why different organ allografts respond differently to the same tolerance induction protocol. RECENT

findingsAllograft tolerance has been achieved in experimental and clinical kidney transplantation. Inducing tolerance in experimental recipients of heart and lung allografts has, however, proven to be more challenging. New protocols being developed in nonhuman primates based on mixed chimerism and cotransplantation of tolerogenic organs may provide mechanistic insights to help overcome these challenges. SUMMARY: Tolerance induction protocols that are successful in patients transplanted with 'tolerance-prone' organs such as kidneys and livers will most likely not succeed in recipients of 'tolerance-resistant' organs such as hearts and lungs. Separate clinical trials using more robust tolerance protocols will be required to achieve tolerance in heart and lung recipients.

Indexed as

Immune ToleranceAnimalsChimerismHumansKidney TransplantationOrgan SpecificityTransplantation, Homologous

Identifiers

PMID26147678
PMCPMC4523268

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.